PT  - JOURNAL ARTICLE
AU  - Haim-Boukobza, Stéphanie
AU  - Roquebert, Benedicte
AU  - Trombert-Paolantoni, Sabine
AU  - Lecorche, Emmanuel
AU  - Verdurme, Laura
AU  - Foulongne, Vincent
AU  - Selinger, Christian
AU  - Michalakis, Yannis
AU  - Sofonea, Mircea T.
AU  - Alizon, Samuel
TI  - Rapid SARS-CoV-2 variants spread detected in France using specific RT-PCR testing
AID  - 10.1101/2021.02.20.21251927
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.20.21251927
4099  - http://medrxiv.org/content/early/2021/02/23/2021.02.20.21251927.short
4100  - http://medrxiv.org/content/early/2021/02/23/2021.02.20.21251927.full
AB  - SARS-CoV-2 variants raise major concerns regarding the control of COVID-19 epidemics. We analyse 40,000 specific RT-PCR tests performed on SARS-CoV-2-positive samples collected between Jan 26 and Feb 16, 2021. We find a high transmission advantage of variants and show that their spread in the country is more advanced than anticipated.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04738331Funding StatementThe authors than the CNRS, the IRD, the ANR and the Occitanie region (PHYEPI project) for funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been approved by the IRB of the CHU of Montpellier (France).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon manuscript publication